Assessing the Outcome of Stereotactic Body Radiation Therapy (SBRT) Compared to Conventional External Beam Radiotherapy (cEBRT) in Spinal Metastases Patient, Does SBRT Result in Better Quality of Life? – Systematic Review

Main Article Content

Aries Rahman Hakim
Komang Agung Irianto
Etty Hary Kusumastuti

Abstract

Introduction: Stereotactic Body Radiation Therapy (SBRT) is an alternative radiation therapy to Conventional External Beam Radiotherapy (cEBRT), which can deliver high doses of radiation to the tumor site and minimize side effects to surrounding healthy tissue. This study aims to evaluate the different outcomes of SBRT and cEBRT for patients with spinal metastases. Materials and methods: A literature search was conducted by the PRISMA guideline using multiple electronic databases: PubMed, ScienceDirect, Sage Journal, CENTRAL, and Web of Science. All studies that fulfilled our PICO criteria were included in this study. Case series, case reports, and reviews were excluded from this review. Results: Studies with a high risk of bias and not assessing the radiotherapy outcome were also excluded. The RoB2 and ROBINS-I tools were used to analyze the quality of the selected studies. Basic data (sample size, sex, and average age of each group) and the outcome summary were tabulated. Based on the inclusion criteria, four literatures were selected for this study. Two out of three studies found that SBRT was more successful in reducing pain. Conclusion: SBRT showed better pain control, OS, progression-free survival (PFS), incidence rate, local failure rate, and adverse event (AE) than cEBRT, but no significant difference in the quality of life.

Downloads

Download data is not yet available.

Article Details

How to Cite
Hakim, A. R., Irianto, K. A., & Kusumastuti, E. H. (2024). Assessing the Outcome of Stereotactic Body Radiation Therapy (SBRT) Compared to Conventional External Beam Radiotherapy (cEBRT) in Spinal Metastases Patient, Does SBRT Result in Better Quality of Life? – Systematic Review. Malaysian Journal of Medicine and Health Sciences, 20(5), 264–269. https://doi.org/10.47836/mjmhs20.5.33
Section
Systematic Reviews

References

Spratt DE, Beeler WH, de Moraes FY, Rhines LD, Gemmete JJ, Chaudhary N, et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol. 2017;18(12):e720–30. doi: 10.1016/S1470-2045(17)30612-5

Eastley N, Newey M, Ashford RU. Skeletal metastases – The role of the orthopaedic and spinal surgeon. Surg Oncol. 2012 Sep;21(3):216–22. doi: 10.1016/j.suronc.2012.04.001

Joaquim AF, Ghizoni E, Tedeschi H, Pereira EB, Giacomini LA. Stereotactic radiosurgery for spinal metastases: a literature review. Einstein (São Paulo). 2013 Jun;11(2):247–55. doi: 10.1590/S1679-45082013000200020

Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu H-KG. Stereotactic Body Radiosurgery for Spinal Metastatic Disease: An Evidence-Based Review. Int J Surg Oncol. 2011;2011:1–9. doi: 10.1155/2011/979214

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016 Oct 12;i4919. Available from: http://www.bmj.com/lookup/doi/10.1136/bmj.i4919

Sahgal A, Myrehaug SD, Siva S, Masucci GL, Maralani PJ, Brundage M, et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol. 2021;22(7):1023–33. doi: 10.1016/S1470-2045(21)00196-0

van de Ven S, van den Bongard D, Pielkenrood B, Kasperts N, Eppinga W, Peters M, et al. Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort. Int J Radiat Oncol Biol Phys. 2020;107(1):39–47. doi: 10.1016/j.ijrobp.2019.12.041

Pielkenrood BJ, van der Velden JM, van der Linden YM, Bartels MMT, Kasperts N, Verhoeff JJC, et al. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases—A Phase 2 Randomized Controlled Trial Within a Prospective Cohort. Int J Radiat Oncol Biol Phys. 2021;110(2):358–67. doi: 10.1016/j.ijrobp.2020.11.060

Zeng KL, Myrehaug S, Soliman H, Husain ZA, Tseng CL, Detsky J, et al. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022;114(2):293–300. doi: 10.1016/j.ijrobp.2022.05.043

van de Ven S, van den Bongard D, Pielkenrood B, Kasperts N, Eppinga W, Peters M, et al. Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort. Int J Radiat Oncol Biol Phys. 2020;107(1):39–47. Available from: https://doi.org/10.1016/j.ijrobp.2019.12.041

Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, et al. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82(1):107–16. doi: 10.1016/j.ijrobp.2010.08.021

Zeng KL, Myrehaug S, Soliman H, Husain ZA, Tseng CL, Detsky J, et al. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022;114(2):293–300. Available from: https://doi.org/10.1016/j.ijrobp.2022.05.043

Pielkenrood BJ, van der Velden JM, van der Linden YM, Bartels MMT, Kasperts N, Verhoeff JJC, et al. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases—A Phase 2 Randomized Controlled Trial Within a Prospective Cohort. Int J Radiat Oncol Biol Phys. 2021;110(2):358–67. Available from: https://doi.org/10.1016/j.ijrobp.2020.11.060

Goblirsch M, Mathews W, Lynch C, Alaei P, Gerbi BJ, Mantyh PW, et al. Radiation Treatment Decreases Bone Cancer Pain, Osteolysis and Tumor Size. Radiat Res. 2004 Feb;161(2):228–34. doi: 10.1667/RR3108

Goblirsch MJ, Zwolak PP, Clohisy DR. Biology of Bone Cancer Pain. Clinical Cancer Research. 2006 Oct 15;12(20):6231s–5s. doi: 10.1158/1078-0432.CCR-06-0682

Felice F De, Piccioli A, Musio D, Tombolini V. The role of radiation therapy in bone metastases management. Oncotarget. 2017 Apr 11;8(15):25691–9. doi: 10.18632/oncotarget.14823

Sierko E, Hempel D, Zuzda K, Wojtukiewicz M. Personalized Radiation Therapy in Cancer Pain Management. Cancers (Basel). 2019 Mar 19;11(3):390. doi: 10.3390/cancers11030390

Sahgal A, Myrehaug SD, Siva S, Masucci GL, Maralani PJ, Brundage M, et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol. 2021;22(7):1023–33. Available from: http://dx.doi.org/10.1016/S1470-2045(21)00196-0

Barzilai O, Versteeg AL, Sahgal A, Rhines LD, Bilsky MH, Sciubba DM, et al. Survival, local control, and health‐related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study. Cancer. 2019 Mar 29;125(5):770–8. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.31870

Sprave T, Verma V, Forster R, Schlampp I, Bruckner T, Bostel T, et al. Quality of Life Following Stereotactic Body Radiotherapy Versus Three-Dimensional Conformal Radiotherapy for Vertebral Metastases: Secondary Analysis of an Exploratory Phase II Randomized Trial. Anticancer Res. 2018 Aug 30;38(8):4961–8. Available from: http://ar.iiarjournals.org/lookup/doi/10.21873/anticanres.12814

Guckenberger M, Mantel F, Sweeney RA, Hawkins M, Belderbos J, Ahmed M, et al. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases. International Journal of Radiation Oncology*Biology*Physics. 2021 Jun;110(2):348–57. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0360301620347416

Iovoli AJ, Yu B, Ma SJ, Farrugia MK, Dexter EU, Yendamuri S, et al. Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review. JTO Clin Res Rep. 2022 Nov;3(11):100417. doi: 10.1016/j.jtocrr.2022.100417

Zhang H, Li J, Yang X, Qiao R, Hu Y-C. Conventional Radiotherapy and Stereotactic Radiosurgery in the Management of Metastatic Spine Disease. Technol Cancer Res Treat. 2020 Jan 1;19:153303382094579. doi: 10.1177/1533033820945798

Faruqi S, Tseng C-L, Whyne C, Alghamdi M, Wilson J, Myrehaug S, et al. Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy. Neurosurgery. 2018 Sep 1;83(3):314–22. doi: 10.1093/neuros/nyx493